• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

教育和激励支持服务:基于移动电话的干预措施在银屑病患者中的试点研究。

Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.

机构信息

Department of Dermatology, University of Naples Federico II, Via Pansini 5, 80131 Naples, Italy.

出版信息

Br J Dermatol. 2013 Jan;168(1):201-5. doi: 10.1111/j.1365-2133.2012.11205.x. Epub 2012 Dec 13.

DOI:10.1111/j.1365-2133.2012.11205.x
PMID:23240729
Abstract

BACKGROUND

Psoriasis is a chronic disease which requires long-term therapy. Therefore, adherence to therapy and patient motivation are key points in controlling the disease. Mobile-phone-based interventions, and in particular text messages (TM), have already been used effectively to motivate patients and improve treatment adherence in many different chronic diseases such as diabetes, cardiovascular disease and asthma.

OBJECTIVES

To evaluate the use of TM in improving treatment adherence and several patient outcomes such as quality of life, disease severity, patient-perceived disease severity and the patient-physician relationship.

PATIENTS AND METHODS

Daily TM, providing reminders and educational tools, were sent for 12 weeks to a group of 20 patients with psoriasis. At the beginning and end of the study the following assessments were performed: Psoriasis Area Severity Index (PASI), Self-Administered Psoriasis Area Severity Index (SAPASI), body surface area (BSA), Physician Global Assessment (PGA), Dermatology Life Quality Index (DLQI), evaluation of patient-physician relationship and adherence to therapy. A matched control group of 20 patients with psoriasis was used for comparison of the same outcomes.

RESULTS

Both patient groups had similar scores for PASI, SAPASI, BSA, PGA and DLQI at baseline. However, after 12 weeks the intervention group reported a significantly better improvement of disease severity as well as quality of life, showing lower values of PASI, SAPASI, BSA, PGA and DLQI with respect to the control group (P<0·05). Moreover, adherence to therapy improved in a statistically significant way (P<0·001) whereas it remained stable in the control group. Similarly, TM interventions led to an optimization of patient-physician communication.

CONCLUSIONS

TM interventions seem to be a very promising tool for the long-term management of patients with psoriasis, leading to an increased compliance to therapy, positive changes in self-care behaviours and better patient-physician relationship allowing improved clinical outcomes and better control of the disease.

摘要

背景

银屑病是一种需要长期治疗的慢性疾病。因此,坚持治疗和患者的积极性是控制疾病的关键。基于手机的干预措施,特别是短信(TM),已经被有效地用于激励患者并提高许多不同慢性疾病(如糖尿病、心血管疾病和哮喘)的治疗依从性。

目的

评估 TM 在提高治疗依从性和改善生活质量、疾病严重程度、患者感知的疾病严重程度和医患关系等患者结局方面的应用。

患者和方法

对 20 例银屑病患者进行为期 12 周的每日 TM,提供提醒和教育工具。在研究开始和结束时进行以下评估:银屑病面积严重程度指数(PASI)、自我评估银屑病面积严重程度指数(SAPASI)、体表面积(BSA)、医生整体评估(PGA)、皮肤病生活质量指数(DLQI)、医患关系评估和治疗依从性。使用 20 例银屑病匹配的对照组进行比较。

结果

两组患者在基线时 PASI、SAPASI、BSA、PGA 和 DLQI 评分相似。然而,12 周后,干预组报告疾病严重程度和生活质量有显著改善,与对照组相比,PASI、SAPASI、BSA、PGA 和 DLQI 值较低(P<0·05)。此外,治疗依从性有统计学意义的改善(P<0·001),而对照组则保持稳定。同样,TM 干预措施导致医患沟通得到优化。

结论

TM 干预措施似乎是治疗银屑病患者的一种非常有前途的工具,可提高治疗依从性,积极改变自我护理行为,并改善医患关系,从而改善临床结局并更好地控制疾病。

相似文献

1
Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.教育和激励支持服务:基于移动电话的干预措施在银屑病患者中的试点研究。
Br J Dermatol. 2013 Jan;168(1):201-5. doi: 10.1111/j.1365-2133.2012.11205.x. Epub 2012 Dec 13.
2
Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.中度至重度斑块状银屑病患者治疗的临床反应与健康相关生活质量结果之间的关系。
Dermatology. 2008;216(3):260-70. doi: 10.1159/000113150. Epub 2008 Jan 11.
3
Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.靶向白细胞介素-17 受体的单克隆抗体治疗银屑病:疗效评价。
Br J Dermatol. 2012 Oct;167(4):710-3; discussion 714-5. doi: 10.1111/bjd.12025.
4
Pilot study on the acceptance of mobile teledermatology for the home monitoring of high-need patients with psoriasis.移动远程皮肤病学用于接受高需求银屑病患者家庭监测的初步研究。
Australas J Dermatol. 2012 Feb;53(1):41-6. doi: 10.1111/j.1440-0960.2011.00852.x. Epub 2012 Jan 6.
5
Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.一种外观可接受的煤焦油溶液治疗中度斑块状银屑病的疗效和耐受性:与卡泊三醇乳膏(卡泊三醇)的对照比较。
Am J Clin Dermatol. 2010;11(4):275-83. doi: 10.2165/11530380-000000000-00000.
6
An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.一项开放标签的前瞻性队列先导研究,旨在评估依那西普在治疗对阿达木单抗反应欠佳的中度至重度斑块状银屑病患者中的疗效和安全性。
J Drugs Dermatol. 2011 Apr;10(4):396-402.
7
An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial.面向银屑病和特应性皮炎患者的教育计划:一项前瞻性随机对照试验。
Br J Dermatol. 2012 Nov;167(5):1025-31. doi: 10.1111/j.1365-2133.2012.11113.x. Epub 2012 Sep 7.
8
A pilot randomized controlled trial to examine the feasibility and efficacy of an educational nursing intervention to improve self-management practices in patients with mild-moderate psoriasis.一项旨在检验教育护理干预改善轻中度银屑病患者自我管理实践的可行性和疗效的初步随机对照试验。
J Eur Acad Dermatol Venereol. 2012 Jun;26(6):738-45. doi: 10.1111/j.1468-3083.2011.04158.x. Epub 2011 Jun 28.
9
Perception of disease and doctor-patient relationship experienced by patients with psoriasis: a questionnaire-based study.银屑病患者对疾病的认知及医患关系:一项基于问卷调查的研究
Am J Clin Dermatol. 2009;10(5):325-30. doi: 10.2165/11311190-000000000-00000.
10
Medication formulation affects quality of life: a randomized single-blind study of clobetasol propionate foam 0.05% compared with a combined program of clobetasol cream 0.05% and solution 0.05% for the treatment of psoriasis.药物剂型影响生活质量:一项关于0.05%丙酸氯倍他索泡沫剂与0.05%丙酸氯倍他索乳膏和0.05%溶液联合方案治疗银屑病的随机单盲研究。
Cutis. 2003 Nov;72(5):407-11.

引用本文的文献

1
Exploring Physicians' Perceptions of Digital Health's Impact on the Patient-Physician Relationship in the Primary Health Care Setting: Qualitative Descriptive Study.探索初级医疗保健环境中医生对数字健康对医患关系影响的看法:定性描述性研究。
J Med Internet Res. 2024 Oct 15;26:e53705. doi: 10.2196/53705.
2
Theoretical Perspectives Underpinning Research on the Physician-Patient Relationship in a Digital Health Practice: Scoping Review.数字健康实践中医患关系研究的理论基础:范围综述
Interact J Med Res. 2024 May 15;13:e47280. doi: 10.2196/47280.
3
Adherence in Atopic Dermatitis.
特应性皮炎的依从性。
Adv Exp Med Biol. 2024;1447:169-190. doi: 10.1007/978-3-031-54513-9_15.
4
Automated Machine Learning Analysis of Patients With Chronic Skin Disease Using a Medical Smartphone App: Retrospective Study.利用医疗智能手机应用程序对慢性皮肤病患者进行自动化机器学习分析:回顾性研究。
J Med Internet Res. 2023 Nov 28;25:e50886. doi: 10.2196/50886.
5
Non-pharmacological interventions for patients with psoriasis: a scoping review.非药物干预措施治疗银屑病患者:范围综述。
BMJ Open. 2023 Nov 24;13(11):e074752. doi: 10.1136/bmjopen-2023-074752.
6
Self-directed self-management interventions to prevent or address distress in young people with long-term physical conditions: A rapid review.自我导向的自我管理干预措施,以预防或解决长期身体状况的年轻人的困扰:快速综述。
Health Expect. 2023 Dec;26(6):2164-2190. doi: 10.1111/hex.13845. Epub 2023 Aug 21.
7
Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic.在COVID-19大流行期间,远程医疗环境与面对面环境中,阿普米拉斯在银屑病和银屑病关节炎患者中的依从性和持续性。
Dermatol Ther (Heidelb). 2023 Sep;13(9):1973-1984. doi: 10.1007/s13555-023-00967-3. Epub 2023 Jul 1.
8
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review.远程皮肤病学在2019年冠状病毒病大流行期间的作用:一项叙述性综述
Clin Cosmet Investig Dermatol. 2022 Dec 19;15:2785-2793. doi: 10.2147/CCID.S377029. eCollection 2022.
9
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative.提升银屑病患者的护理标准:泛欧洲多方利益相关者倡议Epicensus的“行动呼吁”
Dermatol Ther (Heidelb). 2023 Jan;13(1):245-268. doi: 10.1007/s13555-022-00846-3. Epub 2022 Dec 9.
10
A mixed methods systematic review of digital interventions to support the psychological health and well-being of people living with dermatological conditions.一项关于支持皮肤病患者心理健康和福祉的数字干预措施的混合方法系统评价。
Front Med (Lausanne). 2022 Nov 3;9:1024879. doi: 10.3389/fmed.2022.1024879. eCollection 2022.